Found 93 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
PHASE2This study will address the question of whether targeting CMV antigens with...
Location
Children's Hospital Colorado
Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer
PHASE2The main purpose of this study is to evaluate the safety of each study vacc...
Status
Active Not Recruiting
Location
H. Lee Moffitt Cancer Center and Research Institute
Safety and Immunogenicity Study of a Booster Vaccination With a Non-Adjuvanted H5N1 Influenza Vaccine (Follow Up to Study 810501)
PHASE2The purpose of this Phase II follow-up study (to study 810501) is to assess...
Location
University Hospital, Department of Clinical Pharmacology, General Hospital Vienna
Study to Evaluate the Immunogenicity and Safety of a Heterologous Vaccine Regimen Against Ebola
PHASE2This Phase 2 study aims to improve preparedness for future Ebola outbreaks ...
Location
Hôpital Général de Référence de Boende
Study of Proscavax Vaccine in Patients With Localized Prostate Cancer vs Active Surveillance
PHASE2This study will evaluate the safety and efficacy of a prostate cancer vacci...
Location
Beth Israel Deaconess Medical Center
A FIRST IN HUMAN TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF SARS-CoV-2 UQSC2 VACCINE IN HEALTHY ADULTS.
PHASE1This will be a single centre, Phase 1, First-In-Human , Randomized, Active-...
Location
QPharm Pty.Ltd. (Nucleus Network Brisbane)
A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC
PHASE2This is a multi-center Phase II randomized study. We plan to enroll 78 pati...
Evaluation of Meningococcal Immune Response Among Children Who Previously Received MenACWY Conjugate Vaccine
PHASE3The primary objective was to evaluate the persistence of bactericidal antib...
Location
Alabama Clinical Therapeutics 806 St. Vincent's Drive, Suite 615
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer
PHASE1This 2-phase study will determine the safety of treating patients with non-...
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants
PHASE2This is a study to evaluate the immunogenicity, safety, and reactogenicity ...
Location
Benchmark Research (California)